Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer

Activation of c-MET through hepatocyte growth factor (HGF) increases tumorigenesis, induces resistance, and is associated with poor prognosis in various solid tumors. However, the clinical value of serum HGF (sHGF) in patients with advanced non-small cell lung cancer (NSCLC), especially those receiv...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Tsuji, Takahiro, Sakamori, Yuichi, Ozasa, Hiroaki, Yagi, Yoshitaka, Ajimizu, Hitomi, Yasuda, Yuto, Funazo, Tomoko, Nomizo, Takashi, Yoshida, Hironori, Nagai, Hiroki, Maeno, Ken, Oguri, Tetsuya, Hirai, Toyohiro, Kim, Young Hak
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5641091/
https://ncbi.nlm.nih.gov/pubmed/29069748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17895
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi